BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 25736702)

  • 1. Preventability of adverse effects of analgesics: analysis of spontaneous reports.
    Cazacu I; Miremont-Salamé G; Mogosan C; Fourrier-Réglat A; Loghin F; Haramburu F
    Eur J Clin Pharmacol; 2015 May; 71(5):625-9. PubMed ID: 25736702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
    Olivier P; Boulbés O; Tubery M; Lauque D; Montastruc JL; Lapeyre-Mestre M
    Drug Saf; 2002; 25(14):1035-44. PubMed ID: 12408734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol).
    Tavassoli N; Lapeyre-Mestre M; Sommet A; Montastruc JL;
    Br J Clin Pharmacol; 2009 Sep; 68(3):422-6. PubMed ID: 19740400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database.
    Soussan C; Gouraud A; Portolan G; Jean-Pastor MJ; Pecriaux C; Montastruc JL; Damase-Michel C; Lacroix I
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1361-6. PubMed ID: 25183382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in adverse drug reactions related to oral weak opioid analgesics in therapeutic use in adults: A 10-year French vigilances retrospective study.
    Caré W; Pinel S; Dufayet L; Langrand J; Micallef J; Vodovar D
    Fundam Clin Pharmacol; 2023 Dec; 37(6):1205-1217. PubMed ID: 37400273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventability of Adverse Drug Reactions Related to Antibiotics: An Assessment Based on Spontaneous Reporting System.
    Tran HN; Nguyen TNT; Tran NTK; Nguyen LT; Vu HD; Nguyen AH; Trinh NTH
    Ther Innov Regul Sci; 2023 Sep; 57(5):1104-1112. PubMed ID: 37389792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
    Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M
    S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective analysis of the preventability of adverse drug reactions reported in Sweden.
    Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system.
    Sessa M; Bernardi FF; Vitale A; Schiavone B; Gritti G; Mascolo A; Bertini M; Scavone C; Sportiello L; Rossi F; Capuano A
    J Clin Pharm Ther; 2018 Dec; 43(6):867-876. PubMed ID: 30014479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.
    Gustafsson M; Matos C; Joaquim J; Scholl J; van Hunsel F
    Drug Saf; 2023 Nov; 46(11):1133-1148. PubMed ID: 37824028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
    Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports.
    Egron A; Olivier-Abbal P; Gouraud A; Babai S; Combret S; Montastruc JL; Bondon-Guitton E
    Target Oncol; 2015 Jun; 10(2):229-34. PubMed ID: 25056801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.